This study investigates pancreatic cancer in individuals with a strong family history or genetic predisposition. It uses advanced imaging techniques to identify early signs of pancreatic cancer or precursor lesions.
The study evaluates the effectiveness of imaging methods and the development of a blood-based screening test. It focuses on understanding the safety and reliability of these approaches for early detection.
- Who can participate: Individuals aged 50 and older with a family history of pancreatic cancer or specific genetic mutations may participate. Participants must be able to undergo MRI and provide consent.
- Study details: Participants will have MRI scans and donate blood samples for research purposes.
- Study timelines and visits: The study will last 3 years. The study requires 7 visits.